PharmaNutrics: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PharmaNutrics
Largest movements
- Stocks and contracts +€30,329
up €30,329 (+38.0%), from €79,791 to €110,120
- Cash +€29,538
new in 2025: €29,538
mainly Net result for the year (+€77,572) and Receivables within one year (+€25,929)
- Receivables within one year -€25,929
down €25,929 (-20.1%), from €128,752 to €102,823
of which Trade receivables: -€25,595
- Receivables after one year +€6,546
up €6,546 (+4.8%), from €137,476 to €144,022
- Profit (loss) carried forward +€77,572
up €77,572, from -€18,247 to €59,325
- Trade debts -€39,492
down €39,492 (-39.1%), from €101,083 to €61,591
- Tax, wage and social debts +€4,468
up €4,468 (+33.1%), from €13,498 to €17,966
of which Remuneration and social security: +€3,968
- Gross operating margin +€108,513
up €108,513 (+109.7%), from €98,961 to €207,473
- Taxes +€5,926
up €5,926, from -€450 to €5,476
- Financial charges -€5,092
down €5,092 (-18.9%), from €26,987 to €21,895
- Other operating charges +€4,833
up €4,833 (+266.3%), from €1,815 to €6,648
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €350,790 | €389,115 | +€38,325 | +10.9% |
| Fixed assets | 21/28 | €3,801 | €2,611 | -€1,190 | -31.3% |
| Tangible fixed assets | 22/27 | €3,801 | €2,611 | -€1,190 | -31.3% |
| Plant, machinery and equipment | 23 | €3,801 | €1,355 | -€2,446 | -64.4% |
| Furniture and vehicles | 24 | - | €1,257 | +€1,257 | |
| Current assets | 29/58 | €346,990 | €386,504 | +€39,515 | +11.4% |
| Amounts receivable after more than one year | 29 | €137,476 | €144,022 | +€6,546 | +4.8% |
| Other amounts receivable | 291 | €137,476 | €144,022 | +€6,546 | +4.8% |
| Stocks and contracts in progress | 3 | €79,791 | €110,120 | +€30,329 | +38.0% |
| Stocks | 30/36 | €79,791 | €110,120 | +€30,329 | +38.0% |
| Amounts receivable within one year | 40/41 | €128,752 | €102,823 | -€25,929 | -20.1% |
| Trade receivables | 40 | €120,166 | €94,570 | -€25,595 | -21.3% |
| Other amounts receivable | 41 | €8,587 | €8,253 | -€334 | -3.9% |
| Cash at bank and in hand | 54/58 | - | €29,538 | +€29,538 | |
| Deferred charges and accrued income | 490/1 | €971 | - | -€971 | |
| Total equity and liabilities | 10/49 | €350,790 | €389,115 | +€38,325 | +10.9% |
| Equity | 10/15 | €353 | €77,925 | +€77,572 | +21975.8% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€18,247 | €59,325 | +€77,572 | |
| Amounts payable | 17/49 | €350,437 | €311,190 | -€39,247 | -11.2% |
| Amounts payable after more than one year | 17 | €191,939 | €189,785 | -€2,154 | -1.1% |
| Financial debts | 170/4 | €14,677 | €5,991 | -€8,686 | -59.2% |
| Other amounts payable | 178/9 | €177,262 | €183,794 | +€6,532 | +3.7% |
| Amounts payable within one year | 42/48 | €149,674 | €113,615 | -€36,059 | -24.1% |
| Current portion of amounts payable after more than one year | 42 | €8,338 | €8,686 | +€348 | +4.2% |
| Financial debts | 43 | €1,383 | - | -€1,383 | |
| Credit institutions | 430/8 | €1,383 | - | -€1,383 | |
| Trade debts | 44 | €101,083 | €61,591 | -€39,492 | -39.1% |
| Suppliers | 440/4 | €101,083 | €61,591 | -€39,492 | -39.1% |
| Taxes, remuneration and social security | 45 | €13,498 | €17,966 | +€4,468 | +33.1% |
| Taxes | 450/3 | - | €500 | +€500 | |
| Remuneration and social security | 454/9 | €13,498 | €17,466 | +€3,968 | +29.4% |
| Other amounts payable | 47/48 | €25,372 | €25,372 | -€0 | 0.0% |
| Accrued charges and deferred income | 492/3 | €8,824 | €7,789 | -€1,035 | -11.7% |
| Remuneration, social security and pensions | 62 | €95,452 | €95,601 | +€148 | +0.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €4,660 | €3,022 | -€1,638 | -35.2% |
| Other operating charges | 640/8 | €1,815 | €6,648 | +€4,833 | +266.3% |
| Non-recurring operating charges | 66A | €9,619 | - | -€9,619 | |
| Gross operating margin | 9900 | €98,961 | €207,473 | +€108,513 | +109.7% |
| Operating profit (loss) | 9901 | -€12,585 | €102,203 | +€114,788 | |
| Financial income | 75/76B | €794 | €2,740 | +€1,946 | +245.3% |
| Recurring financial income | 75 | €794 | €2,740 | +€1,946 | +245.3% |
| Financial charges | 65/66B | €26,987 | €21,895 | -€5,092 | -18.9% |
| Recurring financial charges | 65 | €26,987 | €21,895 | -€5,092 | -18.9% |
| Profit (loss) for the period before taxes | 9903 | -€38,778 | €83,048 | +€121,826 | |
| Income taxes | 67/77 | -€450 | €5,476 | +€5,926 | |
| Profit (loss) for the period | 9904 | -€38,328 | €77,572 | +€115,901 | |
| Profit (loss) for the period to be appropriated | 9905 | -€38,328 | €77,572 | +€115,901 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 9 October 2026 via checked.be.